Brief: Cleveland Biolabs Q1 Loss Per Share $0.08 Excluding Items

Statera Biopharma

15/05/2019 13:36

May 15 (Reuters) - Cleveland Biolabs Inc  CBLI.O :
    * Q1 LOSS PER SHARE $0.08 EXCLUDING ITEMS
    * CLEVELAND BIOLABS-AS OF MARCH 31, 2019, HAD $3.3 MILLION
IN
CASH, CASH EQUIVALENTS, SHORT-TERM INVESTMENTS, IS EXPECTED TO
FUND OPERATIONS INTO DEC 2019
    * REVENUE FOR Q1 OF 2019 DECREASED TO $0.20 MILLION COMPARED
TO
$0.23 MILLION FOR Q1 OF 2018

Source text for Eikon: https://bit.ly/30l4qFY
Further company coverage:  CBLI.O 

 ((Briefs@thomsonreuters.com;))